| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CVET | Common Stock | Options Exercise | $0 | +24.1 K | +383.09% | $0.00 | 30.4 K | May 13, 2021 | Direct | |
| transaction | CVET | Common Stock | Sale | -$249 K | -9.64 K | -31.72% | $25.79 | 20.7 K | May 14, 2021 | Direct | F1, F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CVET | Restricted Stock Units | Options Exercise | $0 | -24.1 K | -100% | $0.00 | 0 | May 13, 2021 | Common Stock | 24.1 K | Direct | F3, F4 |
| Id | Content |
|---|---|
| F1 | Sale pursuant to 10b5-1 Plan dated March 3, 2021. |
| F2 | Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $25.24 - $26.04. The Reporting Person hereby undertakes, upon request by the Commission staff, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. |
| F3 | Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock or the cash value thereof. |
| F4 | Subject to the Reporting Person's continuous service as a director of the Issuer, 100% of the RSUs will vest on the first anniversary of the grant date. |